Cornerstone Investment Partners’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-46,705
Closed -$4.73M 89
2015
Q4
$4.73M Sell
46,705
-42,510
-48% -$4.42M 0.15% 36
2015
Q3
$8.76M Sell
89,215
-510
-0.6% -$56.6K 0.25% 31
2015
Q2
$10.5M Buy
89,725
+4,465
+5% +$488K 0.25% 32
2015
Q1
$8.37M Buy
85,260
+1,681
+2% +$171K 0.15% 32
2014
Q4
$7.88M Buy
83,579
+289
+0.3% +$29.9K 0.09% 34
2014
Q3
$8.87M Sell
83,290
-28,840
-26% -$2.82M 0.1% 32
2014
Q2
$9.3M Buy
+112,130
New +$8.73M 0.11% 33

Other funds holding GILD

Cornerstone Investment Partners's GILD Position: Q1 2016 in Review

Cornerstone Investment Partners sold out of Gilead Sciences (GILD) in Q1 2016, closing a stake of 46,705 shares — an estimated $4.73M sold.

Cornerstone Investment Partners first reported a position in GILD in Q2 2014 and held it in 7 quarters. The position peaked at $10.5M in Q2 2015. 1,629 funds tracked by Wall St. Rank hold GILD as of Q1 2016.

  • Cornerstone Investment Partners reported no remaining Gilead Sciences position as of Q1 2016 after selling out during the quarter.
  • Cornerstone Investment Partners sold 46,705 Gilead Sciences shares in Q1 2016, an estimated $4.73M.
  • Cornerstone Investment Partners first reported a position in Gilead Sciences in Q2 2014 and held it in 7 quarters.
  • Cornerstone Investment Partners's Gilead Sciences position peaked at $10.5M in Q2 2015.
  • 1,629 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2016.

Based on Cornerstone Investment Partners's 13F filing for Q1 2016, filed 20 Apr 2016.